On July 1, Argenx SE fell 3.05% in regular trading, trading at $899.435 USD/share, with Turnover of $200 million.
Within the Biotechnology sector where Argenx SE belongs, the overall sector performance was mixed. Among individual stocks, AbbVie down 0.59%, Abivax S.A. up 0.52%, Amgen down 0.61%, Gilead Sciences down 0.18%, Can-Fite Biopharma up 41.58%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)